prophylaxis for venous thromboembolism (VTE)

From Aaushi
Jump to navigation Jump to search

Indications

Clinical significance

Management

* see perioperative risk stratification

# TED hose not effective[5]; data supporting efficacy of pneumatic compression devices are almost exclusively limited to surgical patients[1][20]

Notes

* unlikely to become a standard of care

More general terms

Additional terms

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018, 2021.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  2. 2.0 2.1 Journal Watch 22(9):69, 2002 Journal Watch 16(20):158, 1996 N Engl J Med 335:696, 1996
  3. 3.0 3.1 Journal Watch 22(9):69, 2002 Bergqvist D et al Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346:975, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11919306
  4. 4.0 4.1 Prescriber's Letter 10(9):49 2003
  5. 5.0 5.1 5.2 5.3 Journal Watch 24(19):151, 2004 Silbersack Y, Taute BM, Hein W, Podhaisky H. Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br. 2004 Aug;86(6):809-12. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15330019
  6. 6.0 6.1 Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, Turpie AG, Egberts JF, Lensing AW; ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006 Feb 11;332(7537):325-9. Epub 2006 Jan 26. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16439370
  7. 7.0 7.1 Glynn RJ et al A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009 Mar 29 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19329822
    Prescriber's Letter 16(5) 2000 Statins for Venous Thromboembolism Prevention Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250503&pb=PRL (subscription needed) http://www.prescribersletter.com
  8. 8.0 8.1 Lee AY et al Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003 Jul 10;349(2):146-53 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12853587
  9. 9.0 9.1 Gatt ME et al Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical cohort study. Thromb Haemost 2005 91(3):538 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14983230
    Bosson JL et al Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med 2003, 163(21):2613 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14638561
  10. 10.0 10.1 Hull RD et al. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: A randomized trial. Ann Intern Med 2010 Jul 6; 153:8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20621900
  11. 11.0 11.1 Cook D et al for The PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group Dalteparin versus Unfractionated Heparin in Critically Ill Patients New Engl J Med March 22, 2011 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21417952 <Internet> http://www.nejm.org/doi/pdf/10.1056/NEJMoa1014475
  12. 12.0 12.1 12.2 12.3 12.4 12.5 Lederle FA et al Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients and Those With Stroke: A Background Review for an American College of Physicians Clinical Practice Guideline Annals of Internal Medicine November 1, 2011 155(9):602-615 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22041949 <Internet> http://www.annals.org/content/155/9/602.abstract corresponding NGC guideline withdrawn Nov 2016
    Qaseem A et al Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians Annals of Internal Medicine November 1, 2011 155(9):625-682 http://www.annals.org/content/155/9/625.full.pdf+html corresponding NGC guideline withdrawn Nov 2016
  13. 13.0 13.1 13.2 Kakkar AK et al. Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med 2011 Dec 29; 365:2463 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22204723
  14. Guyatt GH et al Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines CHEST February 2012 vol. 141 no. 2 suppl 7S-47S <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22315257 <Internet> http://chestjournal.chestpubs.org/content/141/2_suppl/7S.full
    Alonso-Coello P et al Antithrombotic Therapy in Peripheral Artery Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest. 2012 Feb;141(2 Suppl):e669S-90S. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22315275 (corresponding NGC guideline withdrawn Dec 2017)
  15. 15.0 15.1 15.2 Prescriber's Letter 19(3): 2012 COMMENTARY: Aspirin for VTE Prophylaxis After Hip or Knee Replacement CHART: Drug Options for VTE Prophylaxis After Hip or Knee Replacement Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=280325&pb=PRL (subscription needed) http://www.prescribersletter.com
  16. 16.0 16.1 16.2 Neumann I et al. Oral direct factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: A systematic review and meta-analysis. Ann Intern Med 2012 May 15; 156:710. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22412038
    Sobieraj DM et al. Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: A systematic review. Ann Intern Med 2012 May 15; 156:720. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22412039
  17. 17.0 17.1 17.2 Gomez-Outes A et al. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: Systematic review, meta-analysis, and indirect treatment comparisons. BMJ 2012 Jun 14; 344:e3675 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22700784
  18. 18.0 18.1 Becattini C et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012 May 24; 366:1959 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22621626
    Brighton TA et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012 Nov 4; <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23121403 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1210384
  19. 19.0 19.1 Guyatt GH, Akl EA, Crowther M et al Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):48S-52S PMID: https://www.ncbi.nlm.nih.gov/pubmed/22315255
    Holbrook A, Schulman S, Witt DM et al Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e152S-84S PMID: https://www.ncbi.nlm.nih.gov/pubmed/22315259 (corresponding NGC guideline withdrawn Dec 2017)
    Kahn SR, Lim W, Dunn AS, Cushman M et al Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S PMID: https://www.ncbi.nlm.nih.gov/pubmed/22315261 (corresponding NGC guideline withdrawn Dec 2017)
    Gould MK, Garcia DA, Wren SM et al Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S PMID: https://www.ncbi.nlm.nih.gov/pubmed/22315263 (corresponding NGC guideline withdrawn Dec 2017)
    Falck-Ytter Y, Francis CW, Johanson NA et al Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e278S-325S. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22315265 (corresponding NGC guideline withdrawn Dec 2017)
    Kearon C, Akl EA, Comerota AJ, Prandoni P et al Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e419S-94S. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22315268
  20. 20.0 20.1 Mismetti P, Laporte-Simitsidis S, Tardy B et al Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost. 2000 Jan;83(1):14-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10669147
    Mismetti P, Laporte S, Darmon JY et al Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001 Jul;88(7):913-30. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11442521
  21. Qaseem A, Chou R, Humphrey LL et al Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011 Nov 1;155(9):625-32 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22041951 (corresponding NGC guideline withdrawn Nov 2016)
  22. 22.0 22.1 Bilimoria KY et al Evaluation of Surveillance Bias and the Validity of the Venous Thromboembolism Quality Measure. JAMA. 2013;310(14):1482-1489 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24100354 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1748150
    Livingston EH Postoperative Venous Thromboembolic Disease Prevention, Public Reporting, and Patient Protection. JAMA. 2013;310(14):1453-1454. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24101098 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1748147
  23. 23.0 23.1 Castellucci LA et al. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: Systematic review and network meta-analysis. BMJ 2013 Aug 30; 347:f5133 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23996149 <Internet> http://www.bmj.com/content/347/bmj.f5133
  24. 24.0 24.1 24.2 24.3 Carrier M et al. Management of challenging cases of patients with cancer- associated thrombosis including recurrent thrombosis and bleeding: Guidance from the SSC of the ISTH. J Thromb Haemost 2013 Sep; 11:1760 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23809334 <Internet> http://onlinelibrary.wiley.com/doi/10.1111/jth.12338/abstract
    Oo TH Management of challenging cases of patients with cancer- associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH: a rebuttal. J Thromb Haemost. 2013 Oct 24 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24152379
  25. 25.0 25.1 Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
    Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
    Sugiyama T An update on hip fracture risk associated with anticoagulant therapy: warfarin versus direct oral anticoagulants. Expert Opinion on Drug Safety. 2020 19(10):1219-1220 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32795203
  26. 26.0 26.1 Fowler RA et al Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients. JAMA. Published online November 01, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25362228 <Internet> http://jama.jamanetwork.com/article.aspx?articleID=1921813
  27. 27.0 27.1 Greig MF, Rochow SB, Crilly MA, Mangoni AA. Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence? Age Ageing. 2013;42:428-434 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23557678
    Akl EA, Guyatt G. ACP Journal Club. Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit. Ann Intern Med. 2013 Jul 16;159(2):JC9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23856707
  28. 28.0 28.1 28.2 28.3 The NNT: Elastic Stockings for Deep Vein Thrombosis Prevention After Surgery. http://www.thennt.com/nnt/elastic-stockings-for-deep-vein-thrombosis-prevention-after-surgery/
    The NNT: Elastic Stockings Plus Medical Therapy for Deep Vein Thrombosis Prevention After Surgery. http://www.thennt.com/nnt/elastic-stockings-plus-medical-therapy-for-deep-vein-thrombosis-prevention-after-surgery/
    Sachdeva A, Dalton M, Amaragiri SV, Lees T. Graduated compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2014 Dec 17;12:CD001484. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25517473
  29. 29.0 29.1 The NNT: Graduated Compression Stockings for Prevention of Deep Vein Thrombosis in Stroke Patients
    Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PA. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD001922 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20687069
  30. 30.0 30.1 Hostler DC et al. Validation of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score. Chest 2016 Feb; 149:372 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26867833
  31. 31.0 31.1 Cohen AT, Harrington RA, Goldhaber SZ et al. Extended thromboprophylaxis with betrixaban in acutely ill medical patients. N Engl J Med 2016 May 27 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27232649
  32. Balk EM, Ellis AG, Di M, Adam GP, Trikalinos TA. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update. Systematic Review Update. Comparative Effectiveness Review No. 191. (Prepared by the Brown Evidence-based Practice Center under Contract No. 290-2015-00002-I.) AHRQ Publication No. 17-EHC021-EF. Rockville, MD: Agency for Healthcare Research and Quality; June 2017. http://www.effectivehealthcare.ahrq.gov/reports/final.cfm
  33. 33.0 33.1 33.2 33.3 33.4 Anderson DR, Dunbar M, Murnaghan J Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med 2018; 378:699-707. Feb 22, 2018 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29466159 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1712746
  34. NEJM Knowledge+ Question of the Week. Feb 6, 2018 https://knowledgeplus.nejm.org/question-of-week/1594/
  35. 35.0 35.1 35.2 American Academy of Nursing Twenty-Five Things Nurses and Patients Should Question Choosing Wisely. An initiative of the ABIM Foundation Released April 19, 2018 (21-25) http://www.choosingwisely.org/societies/american-academy-of-nursing/
  36. 36.0 36.1 Grant PJ, Conlon A, Chopra V, Flanders SA. Use of venous thromboembolism prophylaxis in hospitalized patients. JAMA Intern Med 2018 May 21 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29800008
  37. 37.0 37.1 Spyropoulos AC, Ageno W, Albers GW et al. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med 2018 Aug 26; PMID: https://www.ncbi.nlm.nih.gov/pubmed/30145946 Free full text https://www.nejm.org/doi/10.1056/NEJMoa1805090
  38. 38.0 38.1 Carrier M, Abou-Nassar K, Mallick R et al Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. Dec 3, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30511879 https://www.nejm.org/doi/full/10.1056/NEJMoa1814468
  39. 39.0 39.1 Arabi YM, Al-Hameed F, Burns KEA et al. Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N Engl J Med 2019 Feb 18; PMID: https://www.ncbi.nlm.nih.gov/pubmed/30779530 https://www.nejm.org/doi/10.1056/NEJMoa1816150
  40. 40.0 40.1 Heijboer RRO, Lubberts B, Guss D, Johnson AH, Moon DK, DiGiovanni CW. Venous thromboembolism and bleeding adverse events in lower leg, ankle, and foot orthopaedic surgery with and without anticoagulants. J Bone Joint Surg Am 2019 Mar 20; 101:539 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30893235
  41. 41.0 41.1 Lewis S, Glen J, Dawoud D et al Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: a systematic review and network meta-analysis. Lancet Haematology. Published:August 20, 2019 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31426937 https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(19)30155-3/fulltext
    Koziel M, Lip GYH Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement. Lancet Haematology. Published:August 20, 2019 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31444125 https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(19)30164-4/fulltext
  42. 42.0 42.1 42.2 Matharu GS, Kunutsor SK, Judge A et al Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement. A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med. Published online February 3, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32011647 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2759736
  43. 43.0 43.1 Chen CY, Tseng CN, Hsieh MJ et al Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism. JAMA Netw Open. 2021;4(2):e2036304 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33533929 Free article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2775823
  44. 44.0 44.1 ICM-VTE General Delegates. Recommendations from the ICM-VTE: General. J Bone Joint Surg Am 2022 Mar 16; 104:Suppl 1:4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35315607 https://journals.lww.com/jbjsjournal/Fulltext/2022/03161/Recommendations_from_the_ICM_VTE__General.2.aspx
    ICM-VTE Hip & Knee Delegates. Recommendations from the ICM-VTE: Hip & Knee. J Bone Joint Surg Am 2022 Mar 16; 104:Suppl 1:180 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35315610 https://journals.lww.com/jbjsjournal/Fulltext/2022/03161/Recommendations_from_the_ICM_VTE__Hip___Knee.5.aspx
  45. Schunemann HJ, Cushman M, Burnett AE et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and non-hospitalized medical patients. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30482763 PMCID: PMC6258910 Free PMC article
  46. 46.0 46.1 Key NS, Khorana AA, Kuderer NM Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020 Feb 10;38(5):496-520 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31381464
  47. Sugiyama T An update on hip fracture risk associated with anticoagulant therapy: warfarin versus direct oral anticoagulants. Expert Opinion on Durg Safety. 2020 19(10):1219-1220 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32795203
  48. 48.0 48.1 Eck RJ et al. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: Systematic review and network meta-analysis. BMJ 2022 Jul 4; 378:e070022. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35788047 PMCID: PMC9251634 Free PMC article https://www.bmj.com/content/378/bmj-2022-070022
  49. 49.0 49.1 49.2 Bistervels IM et al. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): An open-label, multicentre, randomised, controlled trial. Lancet 2022 Oct 28; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36354038 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02128-6/fulltext
  50. 50.0 50.1 Sutzko DC et al. Low to moderate risk non-orthopedic surgical patients do not benefit from VTE chemoprophylaxis. Ann Surg 2022 Dec; 276:e691. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33214487 https://journals.lww.com/annalsofsurgery/Abstract/2022/12000/Low_to_Moderate_Risk_Non_orthopedic_Surgical.27.aspx
  51. 51.0 51.1 Major Extremity Trauma Research Consortium (METRC). Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture. N Engl J Med 2023 Jan 19; 388:203. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36652352 https://www.nejm.org/doi/10.1056/NEJMoa2205973
  52. 52.0 52.1 Riaz IB et al. Comparative effectiveness of anticoagulants in patients with cancer-associated thrombosis. JAMA Netw Open 2023 Jul 3; 6:e2325283. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37486628 PMCID: PMC10366701 Free PMC article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807546
  53. 53.0 53.1 Alexander M et al. Risk-directed ambulatory thromboprophylaxis in lung and gastrointestinal cancers: The TARGET-TP randomized clinical trial. JAMA Oncol 2023 Nov; 9:1536. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37733336 PMCID: PMC10514890 (available on 2024-09-21) https://jamanetwork.com/journals/jamaoncology/fullarticle/2809873
    Khorana AA. Primary thromboprophylaxis in people with cancer - Where next? JAMA Oncol 2023 Nov; 9:1545. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37733351 https://jamanetwork.com/journals/jamaoncology/fullarticle/2809877
  54. 54.0 54.1 Farmakis IT, Christodoulou KC, Hobohm L, et al. Lipid lowering for prevention of venous thromboembolism: a network meta-analysis. Eur Heart J. 2024 Jun 14:ehae361 PMID: https://www.ncbi.nlm.nih.gov/pubmed/38874212